Who
David Colleran
EVP, General Counsel, Corp Sec
Company insider
Files Form 4 as: EVP, General Counsel, Corp Sec, Anika Therapeutics; SVP, Secretary and GC, Insulet.
In numbers
- Trades disclosed
- 108
- Buys
- 2
- Sells
- 6
- Bought
- $72K
- Sold
- $4.5M
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 24 Feb 2016
- Last trade
- 15 Mar 2026
- Last filed
- 17 Mar 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 15 Mar 2026filed 17 Mar 2026 | ANIK Anika Therapeuticsoption or derivative · Medical Devices | SEC FORM 4 Code M | —6,449 at $0.00 | filing |
| 15 Mar 2026filed 17 Mar 2026 | ANIK Anika TherapeuticsMedical Devices | SEC FORM 4 Code M | —6,449 | filing |
| 15 Mar 2026filed 17 Mar 2026 | ANIK Anika TherapeuticsMedical Devices | SEC FORM 4 Code F | $27K1,893 at $14.20 | filing |
| 15 Mar 2026filed 17 Mar 2026 | ANIK Anika Therapeuticsoption or derivative · Medical Devices | SEC FORM 4 Code M | —6,449 at $0.00 | filing |
| 15 Mar 2026filed 17 Mar 2026 | ANIK Anika TherapeuticsMedical Devices | SEC FORM 4 Code M | —6,449 | filing |
| 15 Mar 2026filed 17 Mar 2026 | ANIK Anika TherapeuticsMedical Devices | SEC FORM 4 Code F | $27K1,893 at $14.20 | filing |
| 14 Mar 2026filed 17 Mar 2026 | ANIK Anika TherapeuticsMedical Devices | SEC FORM 4 Code M | —9,388 | filing |
| 14 Mar 2026filed 17 Mar 2026 | ANIK Anika TherapeuticsMedical Devices | SEC FORM 4 Code A | —4,694 at $0.00 | filing |
| 14 Mar 2026filed 17 Mar 2026 | ANIK Anika TherapeuticsMedical Devices | SEC FORM 4 Code F | $59K4,168 at $14.20 | filing |
| 14 Mar 2026filed 17 Mar 2026 | ANIK Anika Therapeuticsoption or derivative · Medical Devices | SEC FORM 4 Code M | —9,388 at $0.00 | filing |
| 14 Mar 2026filed 17 Mar 2026 | ANIK Anika Therapeuticsoption or derivative · Medical Devices | SEC FORM 4 Code M | —9,388 at $0.00 | filing |
| 14 Mar 2026filed 17 Mar 2026 | ANIK Anika TherapeuticsMedical Devices | SEC FORM 4 Code M | —9,388 | filing |
| 14 Mar 2026filed 17 Mar 2026 | ANIK Anika TherapeuticsMedical Devices | SEC FORM 4 Code A | —4,694 at $0.00 | filing |
| 14 Mar 2026filed 17 Mar 2026 | ANIK Anika TherapeuticsMedical Devices | SEC FORM 4 Code F | $59K4,168 at $14.20 | filing |
| 9 Mar 2026filed 11 Mar 2026 | ANIK Anika TherapeuticsMedical Devices | SEC FORM 4 Code M | —5,465 | filing |
| 9 Mar 2026filed 11 Mar 2026 | ANIK Anika TherapeuticsMedical Devices | SEC FORM 4 Code F | $29K1,919 at $14.96 | filing |
| 9 Mar 2026filed 11 Mar 2026 | ANIK Anika Therapeuticsoption or derivative · Medical Devices | SEC FORM 4 Code M | —5,465 at $0.00 | filing |
| 9 Mar 2026filed 11 Mar 2026 | ANIK Anika Therapeuticsoption or derivative · Medical Devices | SEC FORM 4 Code M | —5,465 at $0.00 | filing |
| 9 Mar 2026filed 11 Mar 2026 | ANIK Anika TherapeuticsMedical Devices | SEC FORM 4 Code M | —5,465 | filing |
| 9 Mar 2026filed 11 Mar 2026 | ANIK Anika TherapeuticsMedical Devices | SEC FORM 4 Code F | $29K1,919 at $14.96 | filing |
News
Analyzing Anika Therapeutics (NASDAQ:ANIK) & ADMA Biologics (NASDAQ:ADMA)ANIK · dailypolitical.com · 13 Oct 2026
0 headlines in the last 90 days name David Colleran; 1 article from the last 14 days about the 2 companies they traded most, at most three about any one of them.